Science Pool

From Development to Delivery: How Continuous Manufacturing is Redefining the Commercial Landscape for Biologics

Posted by Evotec on Jul 17, 2024 3:48:56 PM

Just- Evotec Biologics is pioneering a new era in biomanufacturing. Transitioning to our intensified continuous production before manufacturing at commercial scale can drive value creation in a late-stage manufacturing process. Additionally, as we offer a short feasibility study, this is a low-risk method for evaluating the benefits our workflow can bring, without impeding development timelines.

Learn More

Tags: Oncology, Articles & Whitepapers, Formulation & CMC, Biologics, Immunology & Inflammation